Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method and composition based on tiny RNA for liver cirrhosis and early liver cancer diagnosis

A diagnostic composition, tiny technology, applied in biochemical equipment and methods, microbial assay/examination, etc., capable of solving problems such as sensitivity

Inactive Publication Date: 2013-02-20
BEIJING YOUAN HOSPITAL CAPITAL MEDICAL UNIV
View PDF0 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although a lot of research has been invested in the diagnosis of liver fibrosis / cirrhosis and liver cancer, and some progress has been made, the serological early diagnosis of liver fibrosis / cirrhosis and liver cancer is still a bottleneck in clinical practice, and requires sensitive and specific Non-invasive serological indicators, especially those based on miRNA

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method and composition based on tiny RNA for liver cirrhosis and early liver cancer diagnosis
  • Method and composition based on tiny RNA for liver cirrhosis and early liver cancer diagnosis
  • Method and composition based on tiny RNA for liver cirrhosis and early liver cancer diagnosis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] Embodiment 1 research object

[0045] A total of 122 subjects were used in this study, which were divided into patient group and healthy normal people group, and the patient group was further divided into three groups: chronic hepatitis B group (hereinafter referred to as hepatitis B group, 30 cases), hepatitis B-related cirrhosis group ( Hereinafter referred to as liver cirrhosis group, 30 cases) and hepatitis B related liver cancer group (hereinafter referred to as liver cancer group, 32 cases); healthy normal people group (hereinafter referred to as normal group, 30 cases). The study complies with the requirements of the Declaration of Helsinki, and volunteers have been informed about the use of their blood, tissue samples and clinical data.

[0046] All patients in the patient group were HBsAg positive and had no other types of liver diseases such as chronic hepatitis C, alcoholic liver disease, autoimmune liver disease or metabolic liver disease. All data were o...

Embodiment 2

[0047] Example 2 Serum Sample Acquisition and Sample RNA Extraction

[0048] For the patient group, 10ml of peripheral blood was collected from the patients before liver biopsy or operation and stored in serum test tubes. For the normal group, 10ml of peripheral blood from healthy normal people were collected and stored in serum test tubes. The tubes were centrifuged at 1500 g for 10 min at 4°C. The serum was then aliquoted and centrifuged at 3000 g for 15 min at 4°C to remove cell debris and other residual cells. Serum samples were stored at -80°C.

[0049]All RNA was extracted from 200 μl of serum using the Serum Total RNA Extraction Kit (QuantoBio, Beijing, CN). First, add 200 μl lysis buffer (Lysis Buffer) to each sample, vortex evenly; then add 40 μl lysis enhancer solution (Lysis Enhancer Solution), shake and mix by hand for 15 seconds; then add 440 μl acidified phenol: chloroform (Acidfied Phenol :Chloroform), shake and mix by hand for 30s. Centrifuge at 16,000 g...

Embodiment 3

[0050] Embodiment 3 Reverse transcription obtains cDNA

[0051] cDNA is reverse transcribed from RNA by polyadenylation. Mix 10pg-1μg of total RNA template with 2μl 10× buffer (buffer), 2μl dATP (10mM), 0.5μl polyA polymerase (NEB), 0.5μl ribonuclease (RNase) inhibitor (Promega) and no ribonuclease Water (RNase freewater) (Promega) was mixed to a final volume of 20 μl, and incubated at 37°C for 1h. Then add 1 μl 0.5 μg / μl RT primer (QuantoBio, Beijing, CN) to the reaction tube, incubate at 70°C for 5 minutes and immediately incubate on ice for at least 2 minutes to break the secondary structure of RNA and primers. Finally, the above 20 μl reaction mixture was mixed with 4 μl 5× buffer (buffer), 1 μl dNTP (10 mM) (Sigma), 0.5 μl M-MLV reverse transcriptase (Promega), 0.5 μl ribonuclease (RNase) inhibitor (Promega) , 10 μl polyA reaction mixture and 4 μl RNase free water (Promega), incubated at 42°C for 1h. Undiluted cDNA templates were stored at -20°C for future use.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a method and a composition based on tiny RNA for liver cirrhosis and early liver cancer diagnosis. The invention also provides application of the tiny RNA and / or a detection primer of the tiny RNA in preparation of the composition for liver fibrosis / liver cirrhosis and liver cancer diagnosis. The invention discloses and proves that a serum miRNA-101-5p level can be used as a potential noninvasive index for early diagnosis of hepatitis B / liver cirrhosis related liver cancers for the first time and can also be used as an index related to liver fibrosis / liver cirrhosis diagnosis.

Description

technical field [0001] The present invention relates to the field of biotechnology, more specifically, the present invention relates to methods and compositions based on microRNA for early diagnosis of liver fibrosis / cirrhosis and liver cancer. Background technique [0002] Hepatic fibrosis is a repair mechanism after liver cell injury. Once it develops into diffuse nodular hyperplasia, the normal liver tissue structure is disordered, and cirrhosis of the liver is formed. Cirrhosis is a major risk factor for liver cancer. Currently, diagnostic methods for liver fibrosis / cirrhosis include: liver histopathological examination, clinical evaluation, serum biochemical indicators, imaging examination, transient elastic wave scanning (Fibroscan), proteomics and glycomics techniques. However, these methods have low sensitivity and specificity, or are expensive, which limits their convenient clinical use. [0003] Liver cancer is the fifth most common cancer and the third deadliest...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/68
Inventor 闾军谢云郭佳田洲
Owner BEIJING YOUAN HOSPITAL CAPITAL MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com